2024
The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions
Alameddine D, Damara F, Pinto Rodriguez P, Huttler J, Slade M, Arhuidese I, Aboian E, Ochoa Chaar C. The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions. Annals Of Vascular Surgery 2024, 103: 47-57. PMID: 38387798, DOI: 10.1016/j.avsg.2023.12.071.Peer-Reviewed Original ResearchImpact of cilostazolPeripheral vascular interventionsPeripheral arterial diseaseTreatment of intermittent claudicationRates of long-term mortalityPeripheral vascular interventional proceduresKaplan-Meier methodCongestive heart failureLong-term mortalityLong-term outcomesEndovascular peripheral interventionsRenal complicationsPatient demographicsBaseline characteristicsHeart failureDiabetes mellitusArtery diseaseIntermittent claudicationCilostazolPatientsVascular interventionsPeripheral interventionsClaudicationOutcomesIntervention
2012
To BAM or Not to BAM?: A Closer Look at Balloon-Assisted Maturation
DerDerian T, Hingorani A, Ascher E, Marks N, Jimenez R, Aboian E, Jacob T, Boniscavage P. To BAM or Not to BAM?: A Closer Look at Balloon-Assisted Maturation. Annals Of Vascular Surgery 2012, 27: 104-109. PMID: 23092734, DOI: 10.1016/j.avsg.2012.06.009.Peer-Reviewed Original ResearchConceptsBalloon-Assisted MaturationAutogenous arterio-venous fistulaPost-procedural hematomaVascular access databaseVolume flow measurementsPast medical historyArterio-venous fistulaCommon risk factorsSize of balloonSuccessful maturationAssisted maturationPostoperative duplexWall hematomaDilatation proceduresDiabetes mellitusBalloon groupRetrospective studyHematoma formationMedical historyRisk factorsDifferent balloon sizesUltrasound guidanceAggressive approachBalloon sizeRetrospective analysis